Foreign Investment Screening in Ukraine: What US Investors Need to Know

Table of Contents

• Why Investment Screening Now Matters for US-Backed Deals
  • Ukraine’s Shift Toward Foreign Investment Screening
  • Between the US and the EU: Competing Reference Models
• Two Competing Legislative Approaches
  • Model One: Narrow Sector-Based Screening (Bill No. 14062)
  • Model Two: Risk-Based Alternative (Bill No. 14062-1)
  • Why the Choice Between Models Matters
• What US Investors and Deal Counsel Should Factor In
• Next Steps

~ 18 minutes of reading

Ukraine is introducing a foreign direct investment screening regime as part of a broader evolution of its foreign investment regulation. For US-backed cross-border investments, this is no longer a background policy development. Once adopted, the new framework will begin to influence deal timelines, structuring choices, the allocation of regulatory risk, and, in some cases, whether closing can take place at all.

This shift is driven by practical developments rather than abstract security theory. Ukraine is simultaneously fighting a war, planning large-scale reconstruction, and integrating technologies that increasingly blur the line between civilian and dual-use applications. As a result, transactions that would previously have been treated as routine commercial investments may now be viewed through a different lens. Energy assets, manufacturing capacity, technology-focused businesses, and data-heavy operations will no longer be assessed solely by reference to the parties’ valuations or market shares. Review authorities may tend to focus on more concrete issues: who will exercise control after closing, how tightly the asset is connected to critical infrastructure or sensitive data, and whether its continued operation could become relevant in a disruption or crisis scenario in the country. In some cases, the issue may be addressed not from the perspective of what the Ukrainian business does today, but from what it could do once ownership or control changes.

As a result, Ukraine is moving away from its historical position as an almost entirely open investment jurisdiction. Foreign capital remains welcome, but certain transactions will now trigger additional regulatory review based on their risk profile rather than their formal sector classification. For dealmakers, this places foreign investment screening squarely within the transactional workflow, rather than at the margins of regulatory compliance.

From a deal perspective, the real question is not whether a foreign investment screening regime will exist, but how it will work in practice once transactions begin to flow through it. In practical terms, everything will depend on how the screening mechanism is designed and applied. A narrow scope of review, predictable decision-making, and meaningful room for negotiated remedies can turn screening into a manageable step in transaction planning. Excessive discretion or unclear standards, by contrast, risk turning foreign investment screening into a genuine execution issue that affects pricing, timelines, and even deal viability.

US investors come to this discussion with a well-established point of reference. In the United States, foreign investment screening is treated as a transaction-specific process rather than an open-ended regulatory relationship. Review is centralized, risk assessment follows a recognizable structure, and in sensitive cases, there is a clearly identifiable escalation point at the political level. For deal teams, this matters. Screening exposure can usually be identified early, potential remedies can be discussed upfront, and there is a shared understanding of how and where final decisions are made.

 Importantly, the US model treats screening as an assessment of a specific transaction rather than an ongoing supervisory relationship with the investor.

These assumptions form the implicit baseline that US investors are likely to bring to new jurisdictions. Ukraine, however, cannot simply replicate that model — not only for institutional reasons, but also because of its legal trajectory toward the European Union.

Unlike the United States, the EU has deliberately avoided creating a single supranational “CFIUS-style” authority. Instead, the European approach is built around coordination rather than centralization. EU law preserves national decision-making power while embedding it into a structured framework of information exchange, peer review, and non-binding opinions at the EU level. The emphasis is not on who the investor is in abstract terms, but on how a particular transaction may affect security or public order across interconnected markets and supply chains.

For Ukraine, this distinction is not theoretical. As a candidate country, Ukraine is expected to progressively align its foreign investment legal framework with the EU acquis. That alignment does not require copying any single institutional model, but it does impose clear constraints. Screening mechanisms must be procedurally transparent, risk-based rather than sector-formalistic, and compatible with cross-border coordination. Blanket prohibitions, permanent investor monitoring, or highly discretionary administrative controls sit uneasily with that logic.

This creates a structural tension that matters directly for dealmaking. US investors may instinctively expect a centralized security review resembling the American model. At the same time, Ukraine’s regulatory design space is shaped by European legal principles that prioritize proportionality, procedural safeguards, and transaction-specific analysis over broad executive discretion.

Understanding this dual reference point is essential. Ukraine’s emerging foreign investment regulation is being developed at the intersection of two different legal cultures: the American security-driven screening model familiar to US deal counsel, and the EU coordination-based framework that defines Ukraine’s integration pathway. How Ukraine reconciles these approaches will determine whether foreign investment screening becomes a manageable element of transaction planning — or a source of structural uncertainty for cross-border investments.

This article examines Ukraine’s emerging approach to foreign investment screening, focusing on how competing legislative models differ, how they affect transaction structuring, and what US investors and deal counsel should factor into their planning as Ukraine’s investment framework continues to evolve.

Ukraine is not introducing foreign investment screening in a vacuum. Two competing legislative proposals—Bill No. 14062 and alternative Bill No. 14062-1—reflect two distinct regulatory philosophies, each with distinct implications for deal structuring, timing, and closing certainty.

For US investors and counsel, the key issue is not which draft is “more correct” politically, but how each model would operate in practice once transactions begin to require screening clearance.

Bill No. 14062 proposes a relatively narrow foreign investment screening regime, built around three predefined categories of “sensitive” investments:

• operators of critical infrastructure (based on a government registry);
• exploitation of strategically important natural resources;
• activities involving military or dual-use goods.

From a deal perspective, this model relies on formal triggers:

• acquisition of more than 25% of voting rights;
• appointment rights over executive bodies;
• other classic indicators of corporate control.

If an investment falls outside these predefined sectors or does not meet the formal control thresholds, it may be excluded from the screening regime.

However, once screening is triggered, the process becomes highly centralized and administrative. Under this approach, the final decision sits with a central executive authority responsible for investment policy, assisted by an inter-agency advisory body. The statute itself remains deliberately high-level, deferring most procedural detail—including timelines and risk-assessment mechanics—to future secondary regulations.

From a deal perspective, the weaknesses of this structure become visible once a transaction actually enters the screening process. Because the regime is anchored to a closed list of sectors and formal control thresholds, it leaves little room to account for meaningful differences between transactions that technically fall within the same category. A low-risk minority investment and a transaction that raises genuine strategic concerns may be funneled through the same process, simply because they touch the same regulated sector.

Another source of uncertainty is the extent to which decisions are deferred to post-adoption rulemaking. Critical elements — review periods, coordination among authorities, and substantive assessment criteria — are not settled in the statute itself. In the early stages of implementation, this is likely to lead to inconsistent practices and unpredictable timelines, particularly for deals with fixed signing-to-closing windows.

Put simply, this model prioritizes rapid deployment of regulatory control over procedural refinement. While that trade-off may be defensible from a governmental standpoint, it makes transaction risk harder to price and harder to manage at the structuring stage.

Against that backdrop, the alternative proposal follows a materially different logic.

Bill No. 14062-1 takes a fundamentally different approach. Rather than starting from a closed list of sectors, it introduces a risk-based foreign investment screening framework focused on the substance of the transaction.

Screening may be triggered not only by control acquisitions, but also by:

• acquisition of significant assets;
• access to critical technologies, data, or infrastructure;
• structural rights that create material influence without formal control.

The draft explicitly requires consideration of:

• investor characteristics (including state influence or funding);
• technology and data sensitivity;
• supply-chain implications;
• geopolitical and sanctions context.

This approach is far closer to how US counsel already think about CFIUS exposure—screening becomes a function of risk profile rather than corporate form.

Under this model:

• low-risk transactions may clear with conditions;
• mitigation measures are central, not exceptional;
• outright prohibition is positioned as a last resort.

The draft assigns the screening function to Ukraine’s Antimonopoly Committee, reflecting an attempt to leverage an institution with experience in complex transaction reviews and procedural discipline.

Deal impact risks under this model are:

• broader screening scope, including non-controlling investments;
• higher upfront diligence burden;
• increased importance of early transaction structuring and risk mitigation planning.

From a US deal-making perspective, the distinction between the two drafts is not academic.

Bill No. 14062 favors formal certainty but risks rigidity and administrative opacity.

Bill No. 14062-1 favors analytical depth and mitigation, but expands screening exposure and front-loads legal work.

In both cases, foreign investment screening will become a closing condition rather than a background compliance issue.

The unresolved question is which philosophy Ukraine ultimately adopts—and whether the final regime blends elements of both.

Either way, US investors should assume that:

• foreign investment screening will affect deal timelines;
• screening risk must be assessed at the term-sheet stage;
• mitigation strategies will increasingly shape transaction structure.

Regardless of which legislative model Ukraine ultimately adopts, one conclusion is already clear: foreign investment screening will no longer be a peripheral compliance issue. For US-backed transactions, it is poised to become a deal-critical variable that affects timelines, structuring decisions, risk allocation, and closing certainty, much as merger control, sanctions compliance, or sector-specific licensing do.

The practical implication is straightforward. Screening risk in Ukraine will need to be assessed early—at the term sheet and structuring stage—rather than deferred until signing or closing. Once a transaction triggers screening, clearance is likely to become a formal condition precedent, with direct consequences for long-stop dates, termination rights, and interim operating covenants. Treating screening as an afterthought will materially increase execution risk.

From a structuring perspective, the key analytical question is no longer limited to formal control thresholds. Both legislative models point toward a broader inquiry into whether a transaction creates practical leverage over sensitive assets, technologies, data, or infrastructure. Minority investments, asset deals, governance rights, access arrangements, and veto powers may all become relevant in ways that are familiar to US counsel from CFIUS-style analysis. The substance of influence matters at least as much as its corporate form.

Equally important is the role of mitigation. Under a risk-based screening framework, mitigation measures are not an exceptional remedy reserved for problematic transactions. They are often the primary mechanism for achieving clearance. Restrictions on access to data or technology, governance ring-fencing, operational carve-outs, localization commitments, or conditional rights can all become integral elements of transaction design rather than post hoc concessions. Deals that are structured with mitigation in mind from the outset are far more likely to move through screening efficiently.

At the same time, investors should expect a period of institutional and procedural uncertainty as Ukraine’s screening regime is implemented in practice. Secondary regulations may lag behind primary legislation, and early cases will inevitably shape administrative practice. This does not make transactions unworkable, but it does raise the premium on early regulatory mapping, conservative timeline planning, and clear allocation of screening-related risk between the parties.

Finally, Ukraine should be approached as a legal system in transition, developing its foreign investment regulation at the intersection of American security-driven screening concepts and European principles of proportionality, procedural safeguards, and coordination. For US investors and their counsel, the appropriate response is not to avoid screening risk, but to price it, structure around it, and manage it proactively as part of standard cross-border deal architecture.

Planning a Ukraine transaction in energy, infrastructure, manufacturing, technology, or data‑driven services?

Foreign investment screening in Ukraine is moving from theory to deal reality. We support US investors and deal counsel with early screening risk mapping, foreign investment structuring, mitigation‑ready transaction design, and alignment of CPs, long‑stop dates, and risk allocation with Ukraine’s emerging foreign investment legal framework.

Are you planning an investment in Ukraine and not sure whether it falls under the screening? Contact us – we will assess your situation and offer the optimal deal structure.